Alterations in B-cell Subsets and Clinical Predictors of Response to Telitacicept in Antiphospholipid Antibody-Positive SLE Patients: A Prospective Observational Study - Poll - MDSpire

Alterations in B-cell Subsets and Clinical Predictors of Response to Telitacicept in Antiphospholipid Antibody-Positive SLE Patients: A Prospective Observational Study

  • By

  • Yadi Sun

  • Xu Wang

  • Yueying Wang

  • Ping An

  • Dazhen Guo

  • Qian Xing

  • April 23, 2026

  • 0 min

Share

Original Source(s)

Alterations in B-cell Subsets and Clinical Predictors of Response to Telitacicept in Antiphospholipid Antibody-Positive SLE Patients: A Prospective Observational Study

  • by Yadi Sun, Xu Wang, Yueying Wang, Ping An, Dazhen Guo, Qian Xing

  • April 23, 2026

Related Content

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Insights into Mechanisms and Clinical Consequences

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus